HCA Healthcare Inc (NYSE:HCA) SVP J William Morrow sold 263 shares of the business’s stock in a transaction dated Thursday, February 7th. The stock was sold at an average price of $140.60, for a total transaction of $36,977.80. Following the transaction, the senior vice president now owns 5,922 shares in the company, valued at $832,633.20. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

HCA traded down $0.87 on Monday, hitting $138.66. 1,008,119 shares of the company were exchanged, compared to its average volume of 1,587,261. HCA Healthcare Inc has a fifty-two week low of $93.03 and a fifty-two week high of $147.42. The firm has a market capitalization of $48.02 billion, a P/E ratio of 14.19, a PEG ratio of 1.16 and a beta of 0.80.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Tuesday, January 29th. The company reported $2.99 earnings per share for the quarter, topping the consensus estimate of $2.59 by $0.40. HCA Healthcare had a net margin of 8.11% and a negative return on equity of 91.25%. The company had revenue of $12.27 billion for the quarter, compared to analyst estimates of $12.10 billion. During the same period in the prior year, the business posted $2.12 earnings per share. The firm’s revenue for the quarter was up 6.2% compared to the same quarter last year. Sell-side analysts predict that HCA Healthcare Inc will post 10.02 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Friday, March 29th. Shareholders of record on Friday, March 1st will be given a dividend of $0.40 per share. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.35. This represents a $1.60 annualized dividend and a yield of 1.15%. The ex-dividend date is Thursday, February 28th. HCA Healthcare’s dividend payout ratio is presently 14.33%.

HCA has been the topic of a number of recent analyst reports. Stephens initiated coverage on shares of HCA Healthcare in a research note on Monday, January 14th. They set an “overweight” rating and a $143.00 price target on the stock. SunTrust Banks boosted their price target on shares of HCA Healthcare to $175.00 and gave the stock a “buy” rating in a research note on Wednesday, January 30th. Jefferies Financial Group boosted their price target on shares of HCA Healthcare from $155.00 to $158.00 and gave the stock a “buy” rating in a research note on Wednesday, October 31st. Zacks Investment Research upgraded shares of HCA Healthcare from a “hold” rating to a “buy” rating and set a $151.00 price target on the stock in a research note on Monday, November 26th. Finally, Deutsche Bank initiated coverage on shares of HCA Healthcare in a research note on Thursday, January 3rd. They set a “buy” rating and a $140.00 price target on the stock. Two research analysts have rated the stock with a sell rating, two have assigned a hold rating and eighteen have issued a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus price target of $148.43.

Institutional investors and hedge funds have recently modified their holdings of the business. Benjamin F. Edwards & Company Inc. acquired a new stake in shares of HCA Healthcare in the fourth quarter valued at approximately $25,000. Moody National Bank Trust Division acquired a new stake in shares of HCA Healthcare in the fourth quarter valued at approximately $27,000. Doyle Wealth Management acquired a new stake in shares of HCA Healthcare in the fourth quarter valued at approximately $31,000. Trust Co. of Vermont grew its position in shares of HCA Healthcare by 165.3% in the fourth quarter. Trust Co. of Vermont now owns 329 shares of the company’s stock valued at $41,000 after purchasing an additional 205 shares during the last quarter. Finally, Csenge Advisory Group acquired a new stake in shares of HCA Healthcare in the third quarter valued at approximately $48,000. Institutional investors own 72.85% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This article was originally reported by Daily Political and is owned by of Daily Political. If you are accessing this article on another website, it was illegally copied and republished in violation of U.S. and international copyright and trademark law. The original version of this article can be accessed at https://www.dailypolitical.com/2019/02/11/j-william-morrow-sells-263-shares-of-hca-healthcare-inc-hca-stock.html.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Featured Article: Analyst Ratings Trading

Insider Buying and Selling by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.